OMRON Healthcare to Launch Manufacturing Factory in India
KYOTO, Japan, June 2, 2023 /Kyodo JBN/ --
OMRON Healthcare Co., Ltd.
- Aiming to Realize Its "Going for ZERO" Vision, Zero Heart Attacks and Strokes, OMRON Healthcare Seeks to Accelerate Penetration of Blood Pressure Monitoring in India -
OMRON Healthcare Co., Ltd. (hereinafter referred to as the Company) of Kyoto, Japan, has announced a plan to establish a manufacturing factory at ORIGINS by Mahindra, Chennai (*1), in the Indian state of Tamil Nadu. The factory will begin manufacturing blood pressure monitors in March 2025. Prior to this, the Company signed a memorandum on the establishment of the factory in the presence of Mr. M.K. Stalin, Chief Minister of the Tamil Nadu State Government.
Logo: https://kyodonewsprwire.jp/img/202305305977-O1-BrtOfJD1
In India, an average GDP annual growth rate is expected to be around 6% until 2030 and the population is expected to reach 1.66 billion in 2050 (*2). Owing to the accelerating economic growth and acute population growth, India has now seen a rise in the number of lifestyle disease patients. Among these types of diseases, hypertension is one of the most common causes of cerebro-cardiovascular diseases such as stroke and heart failure. Regular blood pressure monitoring at home is considered to be essential in hypertensive management. However, the penetration rate of blood pressure monitors in India remains low at around 2% (*3).
The establishment of the manufacturing factory and the steady distribution structure are the Company's efforts to deliver blood pressure monitors to as many people as possible in India. The Company believes these initiatives along with a series of disease education campaigns will provide health-related solutions to the people in India. The Company strives to strengthen the reach and availability of home blood pressure monitors across the country and has committed to fulfilling the vision of "Going for ZERO" (achieving zero cerebro-cardiovascular events).
Notes:
(*1) An industrial cluster and a joint venture between Mahindra World City in Chennai and Sumitomo Corporation of Japan
(*2) UN report
(*3) In-house research
"Due to the rapid economic and population growth in India, the number of patients suffering from lifestyle diseases such as hypertension is expected to increase," said Ayumu Okada, President and CEO of OMRON Healthcare Co., Ltd. "The establishment of the manufacturing factory will help us to strengthen the supply chain of blood pressure monitors while exploring the solutions for the disease management and early disease detection before it worsens. For realizing the vision of 'Going for ZERO,' the Company is committed to contributing to the health-related issues of the country."
Mr. M.K. Stalin, Chief Minister of Government of Tamil Nadu (4th left); Ayumu Okada, President and CEO of OMRON Healthcare Co., Ltd. (5th left):
Profile of the factory
Name: OMRON HEALTHCARE MANUFACTURING INDIA PRIVATE LIMITED
Date of establishment: July 14, 2022
Operation start date: March 2025 (TBD)
Area size: approx. 24,000 m2
Items to be manufactured: Blood pressure monitors
Rendering of the factory:
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
このプレスリリースを配信した企業・団体

- 名称 オムロンヘルスケア株式会社
- 所在地 京都府
- 業種 精密機器
- URL https://www.healthcare.omron.co.jp/
過去に配信したプレスリリース
JCL TEAM UKYOを低周波治療器で応援
9/21 15:00
第45回 日本高血圧学会総会に協賛
9/14 15:15
第71回日本心臓病学会学術集会に協賛
9/7 15:00
第33回インド高血圧学会学術大会に協賛
9/5 13:00
欧州循環器学会学術総会に協賛
8/25 11:10
OMRON Healthcare Sponsors ESC Congress 2023
8/24 16:00
温室効果ガス排出量の削減と地域社会との共存に向けて 血圧計の主要部品の国内調達を開始
7/31 15:00